Skip to content

Searching susceptibility to hepatitis A among men who have sex with men in Rio de Janeiro

A cross-sectional study to determine susceptibility to hepatitis A among men who have sex with men in Rio de Janeiro (HEPAGAY)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-7djt4p
Enrollment
Unknown
Registered
2018-10-05
Start date
2019-12-27
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatitis A Antibodies

Interventions

420 subjects will be incuded. Each one will fill a simple questionary. Then, 20mL of blood will be collected and immunocromatographic rapid test anti-HAV IgM and IgG will be performed. In case of susc
Biological/vaccine
H02.781
D20.215.894.899.955.395

Sponsors

Instituto Nacional de Infectologia Evandro Chagas - Fundação Oswaldo Cruz
Lead Sponsor
Instituto Nacional de Infectologia Evandro Chagas - Fundação Oswaldo Cruz
Collaborator

Eligibility

Sex/Gender
Male
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Men aged 18 to 35 years old male at birth who report having had sexual relations with people of the same biological sex in the last six months and live in Rio de Janeiro metropolitan area.

Exclusion criteria

Exclusion criteria: Subjects who have received at least one shot of hepatitis A vaccine at some point in their life. Subjects who live with any autoimmune disease. Any other condition which based on the opinion of the investigator may compromises adherence to the protocol or otherwise interferes with the objectives of the study.

Design outcomes

Primary

MeasureTime frame
Prevalence of immune and susceptible people will be calculated and presented as %.

Secondary

MeasureTime frame
Association between sexual practices and immune or susceptible profile will be calculated by odds ratio.

Countries

Brazil

Contacts

Public ContactAlberto;Marcellus de Lemos;da Costa

Instituto Nacional de Infectologia Evandro Chagas - Fundação Oswaldo Cruz;Instituto Nacional de Infectologia Evandro Chagas - Fundação Oswaldo Cruz

alberto.lemos@ini.fiocruz.br;marcellus.costa@ini.fiocruz.br+55-21-38659595;+55-21-38659595

Outcome results

None listed

Source: REBEC (via WHO ICTRP)